Medicines Discovery Catapult (MDC) is an independent, commercially active not-for-profit drug discovery innovation center. They support drug discovery innovators by providing world-leading scientific and drug discovery expertise, state-of-the-art laboratory facilities and infrastructure, with advanced technologies and analytics. Their focus is to accelerate innovation, support business growth, and help improve patient outcomes. It is co-funded by industry and government, working with partners in the sector, to de-risk inventive technologies, techniques and companies – making them adoptable and investable. Some of MDC's collaborative and national programs in areas of patient need include the Psychiatry Consortium, the Cystic Fibrosis Syndicate, and the Hearing Therapeutics Initiative.
Resource type
Platform
Country
United Kingdom
Access requirements
Purchase